Fc‐engineered EGF‐R antibodies mediate improved antibody‐dependent cellular cytotoxicity (ADCC) against <i>KRAS</i>‐mutated tumor cells
Martin Schlaeth(Christian-Albrechts-Universität zu Kiel), Thomas Valerius(Christian-Albrechts-Universität zu Kiel)
Cited by 44